Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Resectable Pancreatic Cancer × Chemoradiotherapy, Adjuvant × Gastrointestinal × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Esophageal Neoplasms 2 Resectable Pancreatic Cancer 1

Interventions

folfirinox 2 Gemcitabine 2 nimotuzumab 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Colony-Stimulating Factors 1 Cisplatin 1 Chemotherapy, Adjuvant 1 Chemoradiotherapy, Adjuvant 1 Adjuvants, Immunologic 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04737551 2021-02-04

Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study

Shanghai Zhongshan Hospital

Gastrointestinal

Resectable Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡